Ultimo aggiornamento :
29/10/2024
Immunosoppressore   Tacrolimus  
Iniezione
Collirio Soluzione orale
Stabilità in soluzione Stabilità in miscela Fattori che influenzano la stabilità Compatibilità metodo di iniezione Bibliografia pdf
   Struttura chimica  

Nome commerciale   Nome commerciale     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Prograf Australia, Austria, Canada, Chile, Colombia, Danimarca, Finlandia, Francia, Germania, Giappone, Gran Bretagna, Grecia, Iran, Irlanda, Italia, Malaysia, Norvegia, nuova Zelanda, Polonia, Portogallo, Romania, Spagna, Stati Uniti d’America, Svezia, Svizzera, Ungheria
Prograft Belgio, Lussemburgo, Paesi Bassi
Bibliografia   Iniezione   Bibliografia : Tacrolimus  
tipo pubblicazione
207 Rivista Ku YM, Min DI, Kumar V, Noormohamed SE.
Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection.
Am J Health-Syst Pharm 1995 ; 52: 2024-2025.
301 Rivista Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
475 Rivista Taormina D, Abdallah HY, Venkataramanan R, Logue L, Burckart GJ, Ptachcinski RJ, Todo S, Fung JJ, Starzl TE.
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers.
Am J Hosp Pharm 1992 ; 49: 119-122.
479 Rivista Min DI, Brown T, HWang GC.
Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 2964-2966.
814 Rivista Johnson CE, VandenBussche HL, Chio CC, Jacobson PA.
Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration.
Am J Health-Syst Pharm 1999 ; 56: 164-169.
907 Rivista Ku YM, Min DI, Kumar V, Noormohamed SA.
Stability of tacrolimus injection in total parenteral nutrition solution.
J Pharm Technol 1996 ; 12: 58-61.
1415 Rivista Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
JPEN 1999 ; 23: 67-74.
1421 Rivista Johnson CE, Truong NM.
Stability and compatibility of tacrolimus and fluconazole in 0.9% sodium chloride.
J Am Pharm Assoc 1999 ; 39: 505-509.
1982 Rivista Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2108 Rivista Trusley C, Kupiec TC, Trissel LA.
Compatibility of micafungin injection with other drugs during simulated Y-site co-administration.
Int J Pharm Compound 2006 ; 10: 230-232.
2192 Rivista Cochran BG, Sowinski KM, Fausel C, Overholser BR.
Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs.
Am J Health-Syst Pharm 2007 ; 64, 13: 1410-1414.
2247 Rivista Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
2262 Rivista Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3626 Laboratorio Tacrolimus (Prograf®) - Résumé des Caractéristiques du Produit
Astellas Pharma 2014
3827 poster Ghazi I.M, Hamada Y, Nicolau D.P.
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
ASHP Midyear 2015
3828 poster Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829 poster So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
3842 Rivista Lee J.H, Goldspiel B.R, Ryu S, Potti G.K.
Stability of tacrolimus solutions in polyolefin containers.
Am J Health-Syst Pharm 2016 ; 73:137-142.
3915 Rivista Myers A.L, Zhang Y, . Kawedia J.D, Shank B.R, Deaver M.A, Kramer M.A.
Stability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bags
Am J Health-Syst Pharm 2016 ; 73,24: 2083-2088.
3948 Rivista Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P .
Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation.
JPEN 2012 ;30. 416?424.
4521 Rivista Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B.
Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit.
Pharmaceutical Technology in Hospital Pharmacy 2020

  Mentions Légales